Delivery Order SPE2DB20D1100-SPE2DB25FE2C9
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,280.87 for Lupron Depot-PED 30 mg 3-month kits on August 22, 2025, with a completion deadline of August 25, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lupron Depot-PED 11.25 mg 3-month formulation, with a ceiling value of $19,073.66. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran...
- The Defense Logistics Agency awarded a $2,587.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 11.25 mg kits, with an ultimate completion date of August 6, 2025. This non-set-aside award reflects a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a delivery order valued at $33,553.93 to AmerisourceBergen Drug Corp for Lupron Depot-Ped 30 mg 3-month kits, a specialty pharmaceutical product used in pediatric endocrinology treatment. This firm fixed-price delivery order, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,632.97 to AmerisourceBergen Drug Corp for the supply of Lupron Depot-PED 7.5 mg kits under a firm fixed price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded non-set-aside procurement. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a $17,214.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 15 mg kits on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside award was made competitively and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $23,165.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot-Ped 11.25 mg kits. The contract is unclassified as a set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits with a ceiling value of $11,281.85. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The product will be delivered to the company's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, valued at $33,612.02. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a competitively awarded, non-set-aside procurement with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $65,364.83 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE2C9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $54,633.18 to AmerisourceBergen Drug Corp for Lupron Depot-Ped 11.25 mg 3-month supply on August 21, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, is being fulfilled from the vendor's Conshohocken, Pennsylvania location. The award is non-competitive and falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. Lupron Depot-Ped is a specialty pharmaceutical used in pediatric medical treatment, reflecting the breadth of AmerisourceBergen's role as a critical vendor for federal medical procurement. As one of the major pharmaceutical distributors supporting military and veteran healthcare systems, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order represents a routine transaction within the company's larger contractual framework with the Defense Logistics Agency, demonstrating its continued capacity to fulfill specialized pharmaceutical requirements for the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.6k | 8/21/25 |